Dr. Akinyemiju is an Associate Professor of Epidemiology with expertise in cancer epidemiology, cancer biology, epidemiologic methods, and health disparities. Her research interests include quantifying the impact of social (e.g. access to healthcare and structural racism) and biological factors (e.g. metabolic and inflammatory dysregulation) on racial disparities in cancer risk, tumor aggressiveness, quality of treatment and survival. This line of inquiry has resulted in over 100 publications till date. Dr. Akinyemiju is the PI of an NIH funded study examining the role of metabolic dysregulation and associated epigenetic changes in risk of aggressive, hormone-receptor negative breast cancer in women of African descent, and an R01 characterizing racial differences in various healthcare access dimensions, and how these predict poor treatment utilization and lower survival among Black, Hispanic and White ovarian cancer patients. These ultimate goal of these studies is to provide novel, empirical and generalizable insights that can help identify and prioritize specific modifiable factors that can be targeted to reduce cancer disparities and improve care for all patients, findings that will likely be beneficial across a range of cancer types where racial disparities remain an intractable problem.